Sino Biopharmaceutical (HK:1177) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sino Biopharmaceutical Limited has announced the purchase of 8 million shares on October 3, 2024, under its restricted share award scheme, representing about 0.043% of the total shares issued at an average price of HK$3.81 per share. With a total expenditure of approximately HK$30.5 million, the board retains discretion over the number of shares to be awarded and further market purchases under the scheme.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.